Publications for Piiha-Lotta Jerevall
Co-author map based on ISI articles 2007-
Journal Articles
Piiha-Lotta Jerevall, Xiai-Jun Ma, Hongying Li, Ranelle Salunga, Nicole C. Kesty, Mark G. Erlander, Dennis Sgroi, Birgitta Holmlund, Lambert Skoog, Tommy Fornander, Bo Nordenskjöld and Olle Stål
Prognostic utility of HOXB13:IL17BR and Molecular Grade Index in early-stage breast cancer patients from the Stockholm trial
British Journal of Cancer, 2011, 104(11), 1762-1769.
Fulltext  Web of Science® Times Cited: 10 |
Piiha-Lotta Jerevall, Agneta Jansson, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld and Olle Stål
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer
Breast Cancer Research, 2010, 12(4), .
Web of Science® Times Cited: 6 |
Cecilia Gunnarsson, Piiha-Lotta Jerevall, Karl Hammar, Birgit Olsson, Bo Nordenskjöld, Agneta Jansson and Olle Stål
Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
Breast Cancer Research and Treatment, 2008, 108(1), 35-41.
Web of Science® Times Cited: 16 |
Piiha-Lotta Jerevall, Sara Brommesson, Carina Strand, Sofia Gruvberger-Saal, Per Malmström, Bo Nordenskjöld, Sten Wingren, Peter Söderkvist, Mårten Fernö and Olle Stål
Exploring the two-gene ratio in breast cancer – independent roles for HOXB13 and IL17BR in prediction of clinical outcome
Breast Cancer Research and Treatment, 2008, 107(2), 225-234.
Fulltext Web of Science® Times Cited: 23 |
Piiha-Lotta Jerevall, Ahmad Ahmadi, Malin Bergman, Olle Stål and Sten Wingren
Sulfotransferase1A1 and risk of postmenopausal breast cancer
Anticancer Research, 2005, 25(3 C), 2515-2517.
Web of Science® Times Cited: 8 |
Conference Articles
Piiha-Lotta Jerevall, A. Jansson, T. Fornander, L. Skoog, Bo Nordenskjöld and Olle Stål
HOXB13 protein expression predicts the benefit of tamoxifen treatment in breast cancer patients: in CANCER RESEARCH, vol 69, issue 2, Supplement 1, pp 358S-358S
CANCER RESEARCH, 2009.
|
Olle Stål, Piiha-Lotta Jerevall, Xiai-Jun Ma, Hongying Li, Ranelle Salunga, Mark Erlander, Dennis Sgroi, Birgitta Holmlund, Lambert Skoog and Tommy Fornander
Validation of Prognostic Utility of HOXB13:IL17BR and Molecular Grade Index in Early Stage Breast Cancer: in CANCER RESEARCH, vol 69, issue 24, pp 504S-504S
32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium. December 10, San Diego, 2009.
Web of Science® Times Cited: 2
|
Ph.D. Theses
Ph.D., Lic. Theses
